[Diabetic neuropathy]

scientific article published on 01 April 2016

[Diabetic neuropathy] is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00508-015-0930-4
P698PubMed publication ID27052228

P50authorMarkus KoflerQ43196532
P2093author name stringHeidemarie Abrahamian
Monika Lechleitner
Claudia Francesconi
P2860cites workNeuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3.Q46126607
Oxidative stress and autonomic nerve function in early type 1 diabetesQ51152548
The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes.Q53238631
How should peripheral neuropathy be assessed in people with diabetes in primary care? A population-based comparison of four measuresQ59562335
Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications StudyQ69440204
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy StudyQ70651014
Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow upQ71876330
A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathyQ72408304
The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo StudyQ72717809
Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scoresQ73062706
Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patientsQ73373288
Distinctive electrophysiological features of denervated muscle in uremic patientsQ74150680
Longitudinal assessment of the development of diabetic polyneuropathy and associated risk factorsQ74706934
(9) Microvascular complications and foot careQ86396540
Pregabalin for acute and chronic pain in adultsQ24239867
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) GroupQ27860882
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research GroupQ27861088
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the [...]Q28288249
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetesQ29547541
10-year follow-up of intensive glucose control in type 2 diabetesQ29615973
Glucose control and vascular complications in veterans with type 2 diabetesQ29619213
Experimental diabetic neuropathy: an updateQ33706830
Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine & RehabilitationQ33870062
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and TreatmentsQ34153575
Diabetic autonomic neuropathyQ34193010
Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathyQ34218901
Diabetic neuropathy: clinical manifestations and current treatmentsQ34275990
From guideline to patient: a review of recent recommendations for pharmacotherapy of painful diabetic neuropathyQ34439612
Accuracy of the Neuropad test for the diagnosis of distal symmetric polyneuropathy in type 2 diabetesQ35043229
Diagnosis and treatment of diabetic autonomic neuropathyQ35087658
Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trialQ35179957
Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K.Q35225448
Treatment of diabetic polyneuropathy: Update 2006.Q36675881
Diabetes mellitus and the peripheral nervous system: manifestations and mechanismsQ36806531
Neuropathy among the diabetes control and complications trial cohort 8 years after trial completionQ37054976
Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathyQ37212329
Strategies for the diagnosis and treatment of neuropathic pain secondary to diabetic peripheral sensory polyneuropathyQ37338595
Impact of pancreas transplantation on type 1 diabetes-related complicationsQ37654317
Diabetic neuropathy: cellular mechanisms as therapeutic targetsQ37930962
Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathyQ37978264
Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathyQ38093664
Identifying patients with diabetes mellitus who are at risk for lower-extremity complications: use of Semmes-Weinstein monofilamentsQ40937034
The Rochester Diabetic Neuropathy Study: Reassessment of tests and criteria for diagnosis and staged severityQ41116085
Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitorQ43794467
Treatment of diabetic neuropathy and neuropathic pain: how far have we come?Q44018868
Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and managementQ44369533
A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic populationQ44908082
P304page(s)S73-9
P577publication date2016-04-01
P1433published inVienna Clinical WeeklyQ15759796
P1476title[Diabetic neuropathy]
P478volume128 Suppl 2

Search more.